Remedium Retatrutide 30mg Pen

Remedium Retatrutide 30mg Pen

Remedium Retatrutide 30mg Pen is a pre-filled research device designed for controlled laboratory analysis of multi-agonist receptor pathways. This format allows precise dispensing suitable for structured research environments and experimental investigation protocols.

 Key Features

• 30mg high-purity Retatrutide in a ready-to-use pen format

• Sterile, sealed, pre-dosed research device

• Designed for controlled dispensing in experimental settings

• Suitable for research involving multi-agonist metabolic and hormonal signalling pathways

• For laboratory and research use only

How the Research Pen Is Used

Researchers may activate and dispense from the pen device according to laboratory protocol requirements. The unit includes clear segmentation to support controlled experimental measurement.

Research steps commonly include:

• Preparing the pen under sterile conditions

• Using approved dosing instruments or techniques in line with institutional research methodology

• Safely capping, storing, and logging experimental variable use

Refer to your institution’s research framework for methodology. No standardized protocol is prescribed with this product.

Third-Party Laboratory Testing

Each batch of Remedium Retatrutide is independently analyzed by Janoshik Analytical, an ISO-accredited laboratory specializing in peptide characterization.

Latest Test Results (Batch: RETP001):

• Identified Compound: Retatrutide

• Measured Concentration: 10.38 mg/mL

• Purity: 98.564%

• Analysis Date: 17 October 2025

Testing was conducted using validated analytical methods to confirm compound identity, concentration, and purity. A copy of the official laboratory report is provided as an image for transparency and verification.

Storage Guidelines

• Store refrigerated between 2°C and 8°C

• Do not freeze

• Keep sealed when not in active use

• Dispose of used components in accordance with laboratory chemical and sharps disposal protocols